loading

Rocket Pharmaceuticals Inc (RCKT) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
3.28%
46.92
48.51 43.96 52.25 71.15
Interest Income/Expense
0.00%
0.473
0.473 0.473 0.473 0.473
Operating Income/Loss
3.28%
-46.92
-48.51 -43.96 -52.25 -71.15
Income/Loss From Continuing Operations Before Tax
131.84
- -42.54 -50.33 -68.92
Income Tax Expense/Benefit
8.621
- - - -
Net Income/Loss
358.89%
123.21
-47.59 -42.54 -50.33 -68.92
Basic Average Shares
0.63%
112.84
112.13 0.2236 111.57 111.02
Diluted Average Shares
2.12%
114.51
112.13 0.2236 111.57 111.02
Basic Earnings Per Share
359.52%
1.09
-0.42 -0.38 -0.45 -0.62
Diluted Earnings Per Share
357.14%
1.08
-0.42 -0.38 -0.45 -0.62
$6.17
price up icon 0.00%
$6.465
price down icon 0.69%
$8.73
price up icon 1.04%
DNA DNA
$9.96
price up icon 1.01%
$6.515
price down icon 0.69%
WVE WVE
$3.435
price up icon 0.44%
大文字化:     |  ボリューム (24 時間):